Therefore, the synergy of PARP inhibitor (PARPi) and Lapa is a promising strategy to extend NQO1-mediated H2O2 generation, inhibit PARP-driven DNA repair and enhance DNA damages in a tumor-selective manner. The gene discussed is NQO1; the disease is neoplasm.